I sit down with Breakthrough T1D CEO Dr. Aaron Kowalski to trace his journey—from open-source roots and the early CGM days to leading one of the most influential organizations in diabetes. We dig into how the Artificial Pancreas Project helped make CGMs and AID systems mainstream, and why Aaron believes he’ll one day take off his insulin pump. He breaks down today’s cure pathways—cell replacement and regeneration, immune modulation, and prevention—plus Project ACT to accelerate cell therapies. We also cover the stages of type 1 diabetes and the latest on teplizumab, alongside the push for dynamic algorithms and smarter insulins.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   Sign up for Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   ▶️ Watch the video episode   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your medical care team before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.